Loading ...
Sorry, an error occurred while loading the content.
 

Re: [GIWorld-Hepatitis] (repost) PHARMACOKINETICS OF PEGINTERFERON ALFA-2A (40KD, PEGASYS) COMPARED TO PEGINTERFERON ALFA-2B (12KD, PEGINTRON) IN NAIVE PATIENTS WITH CHRONIC HEPATITIS C (CHC)

Expand Messages
  • Tatezi
    Thanks for posting this Claudine...I knew that Pegasys stayed in your system longer than PegIntron which is why I d always hoped to do Pegasys as my second try
    Message 1 of 2 , Jul 24 5:19 AM
      Thanks for posting this Claudine...I knew that Pegasys stayed in your system longer than PegIntron which is why I'd always hoped to do Pegasys as my second try at treatment.
      ----- Original Message -----
      From: claudine intexas
      To: gi
      Sent: Wednesday, July 23, 2003 8:14 PM
      Subject: [GIWorld-Hepatitis] (repost) PHARMACOKINETICS OF PEGINTERFERON ALFA-2A (40KD, PEGASYS) COMPARED TO PEGINTERFERON ALFA-2B (12KD, PEGINTRON) IN NAIVE PATIENTS WITH CHRONIC HEPATITIS C (CHC)


      NATAP - www.natap.org

      EASL. 28th Annual Meeting of the European Association for the Study
      of the Liver. To be held in Istanbul, Turkey March 28-April 1, 2003.
      Cancelled due to war. NATAP reports key selected abstracts.

      PHARMACOKINETICS OF PEGINTERFERON ALFA-2A (40KD, PEGASYS) COMPARED TO
      PEGINTERFERON ALFA-2B (12KD, PEGINTRON) IN NAIVE PATIENTS WITH
      CHRONIC HEPATITIS C (CHC)

      [Non-text portions of this message have been removed]
    Your message has been successfully submitted and would be delivered to recipients shortly.